Stanford Medicine Catalyst, Stanford Medicine’s flagship innovation program to support inventors across the Stanford community in developing and accelerating their most promising health care innovations, is pleased to announce the next open project application window for transformative innovations — to commence on Friday, Sept. 6, 2024. If you are part of the Stanford ecosystem and have been working on a health care innovation that could be a good fit for our program, we would like to hear from you!
Catalyst nurtures and works side-by-side with inventors on innovations that have transformative potential in health care to deliver projects from labs and clinics across our campus to improve the health and well-being of our patients and those around the world. Awarded projects can receive up to $1,000,000 in funding, alongside hands-on resources and mentorship to augment existing innovation teams, spanning: project management, regulatory and market guidance, strategic and business consulting, potential for pilot validation within Stanford Health Care and Stanford Medicine Children's Health, and access to industry experts and investor networks.
Transformative innovations from across the Stanford community (students, faculty, physicians, staff, etc.) are welcomed — spanning therapeutics, to medical devices, to diagnostics, and digital health — provided they can significantly impact health care and are ready to be implemented through advanced prototype development, piloting, in vivo validation, and/or early-stage utilization.
Applications will be received for about 30 days, or until our application capacity is met, and will be reviewed upon receipt. So please don’t delay, to ensure your submission for this cycle.
We look forward to hearing from you!
Catalyst program leaders
Kevin Wasserstein
Executive Director, Stanford Medicine Catalyst
Euan Ashley
Associate Dean, Endowed Professor of Genomics and Precision Health, and Professor of Cardiovascular Medicine, Stanford Medicine
Michael Halaas
Associate Dean, Industry Relations and Digital Health, and COO, Stanford Health Care and School of Medicine
Comentários